期刊文献+

RNA干扰沉默转化生长因子β1基因对大鼠移植肾Smads信号通路的影响 被引量:3

原文传递
导出
摘要 目的探讨转化生长因子pI(TGF-β1)的RNA干扰质粒shRNA-TGF-β1对大鼠移植。肾Smads信号通路的影响。方法以SD大鼠和Wistar大鼠分别作为供、受者,建立大鼠左肾原位移植及移植肾纤维化加快模型。将受者分为3组,质粒组受者肾移植后转染shRNA-TGF-β1质粒,空质粒组受者肾移植后转染空质粒,单纯移植组受者仅行肾移植,术后不转染任何质粒。另取健康Wistar大鼠作为假手术对照组,仅切除其左肾,不进行肾移植和转染任何质粒。质粒转染采用以流体力学为基础的肾脏基因转染技术。移植后1、2和3个月,采用酶联免疫吸附试验检测各组大鼠血清肌酐(SCr)和尿素氮(BUN)的水平,采用逆转录聚合酶链反应法和蛋白质印迹法分别检测各组大鼠移植肾组织中TGF-β1、磷酸化-Smad3(p-Smad3)和p-Smad7的mRNA和蛋白的表达。结果术后各检测时点,质粒组SCr和BUN水平显著高于假手术组(P〈0.Ol或P%0.05),但明显低于空质粒组和单纯移植组(P<O.05或P〈O.01);质粒组TGF-β1的表达显著高于假手术组(P<O.01或P〈0.05),但显著低于空质粒组和单纯移植组(P〈0.05或P〈O.01);质粒组p-Smad3的表达显著高于假手术组(P〈0.01或P〈0.05),但明显低于空质粒组和单纯移植组(P〈0.01或P〈0.05);质粒组p-Smad7表达显著低于假手术组(P%0.01或P〈0.05),但明显高于空质粒组和单纯移植组(P〈0.01或P〈0.05)。结论质粒shRNA-TGF-β1能够显著改善大鼠的移植肾功能,其机制可能是shRNA-TGFβ1可以明显下调信号蛋白p-Smad3的表达,上调p-Smad7的表达,抑制TGF-β1的促纤维化作用,延缓移植肾的纤维化。
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2011年第6期358-362,共5页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献13

二级参考文献49

  • 1刘虹,刘伏友,彭佑铭,袁芳,刘映红.pcDU_6质粒载体介导的TGFβ_1 shRNA抑制TGFβ_1在人腹膜间皮细胞中的表达[J].中南大学学报(医学版),2004,29(5):552-557. 被引量:3
  • 2王平贤,方丽,黄赤兵,范明齐,张艮甫.移植肾TGF-β_1表达与远期肾功能关系的临床研究[J].医学临床研究,2005,22(1):1-4. 被引量:2
  • 3张爱青,甘卫华,潘晓勤,费莉,郭梅,陈荣华.外源性结缔组织生长因子对人肾小管上皮细胞转分化及细胞外基质合成的作用[J].第四军医大学学报,2007,28(12):1108-1111. 被引量:4
  • 4Hariharan S,Johnson C,Bresnahan B,et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996[J]. N Engl J Med, 2000,342(9 ): 605-617.
  • 5Yoshida K,Endo T,Saito T,et al. Cadaveric renal transplantation from non-heart-beating donors with graft survival for more than 10 years [J]. Transplantation Proceedings, 2002,34(7 ): 2604-2607.
  • 6Viklicky O, Matl I, Voska L, et al. TGF-betal expression and chronic allograft nephropathy in protocol kidney graft biopsy[J]. Physiol Res,2003,52 (3):353-360.
  • 7Houlihan C A, Akdeniz A,Tsalamandris C, et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate:effects of angiotensin receptor blockade and sodium restriction[J]. Diabetes Care, 2002,25 (6) : 1072-1077.
  • 8Woo YC. Synergistic effects of mycphenolate mofetil and losartan in a model of chronic cyclosporine nephropathy[J]. Transplantation,2003,75(3) : 309-315.
  • 9lzquierdo M. Short interfering RNAs as a tool for cancer gene therapy [J]. Cancer Gene Therapy, 2005,12: 217-227.
  • 10Yu J Y, DeRuiter S L, Turner D L. RNA interference by expression of short-interfering RNAs and hairpin RNA in mammalian cells[J]. Proc Natl Acad Sci USA, 2002,9 ( 10 ) : 6047-6052.

共引文献14

同被引文献22

  • 1Kojima H, Kosugi T, Sato W, et al. Deficiency of growth factor mid- kine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis[J]. Am j pathol, 2013, 182(2): 410-419.
  • 2Li Y, Sun Y, Liu F, Sun L, et al. Norcantharidin inhibits renal intersti- tial fibrosis by blocking the tubular epithelial-mesenchymal transition [J]. PLoS One, 2013, 8(6): e66356.
  • 3Li X, Yamagata K, Nishita M, et al. Activation of Wnt5a-Ror2 signal- ing associated with epithelial-to-mesenchymal transition of tubular epithelial cells during renalfibrosis [J]. Genes Cells, 2013, 18 (7): 608-619.
  • 4Fu W, Wang Y, Jin Z, et al. Losartan alleviates renal fibrosis by down-regulating HIF-lalpha and up-regulating MMP-9/T1MP-1 in rats with 5/6 nephrectomy[J]. Ren fail, 2012, 34(10): 1297-1304.
  • 5Abdulla MH, Sattar MA, Abdullah NA, et al. The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats[J]. J physiol biochem, 2012, 68(3): 353-363.
  • 6Marshall CS, Cheng AC, Markey PG, et al. Acute post-streptococcal glomernlonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature [J]. Am J Trop Med Hyg, 2011, 85(4): 703-710.
  • 7Jackson S J, Steer AC, Campbell H. Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis [J]. Trop Med Int Health, 2011, 16(1): 2-11.
  • 8Befani CD, Vlachostergios P J, Hatzidaki E, et al. Bortezomib represses HIF-I alpha protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells[J]. J Mol Med (Berl), 2012, 90(1): 45-54.
  • 9Du J, Xu R, Hu Z, et al. PI3K and ERK-induced Racl activation me- diates hypoxia-induced HIF-lalpha expression in MCF-7 breast can- cer cells[J]. PloS one, 2011, 6(9): e25213.
  • 10Xu X, Chen P, Zheng Q, et al. Effect of pioglitazone on diabetic nephropathy and expression of HIF-lalpha and VEGF in the renal tis- sues of type 2 diabetic rats [J]. Diabetes res olin pract, 2011, 93(1): 63-69.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部